Connexin 43 Upregulation by Dioscin Inhibits Melanoma Progression via Suppressing Malignancy and Inducing M1 Polarization

International Journal of Cancer - United States
doi 10.1002/ijc.30872
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Kanglaite Sensitizes Colorectal Cancer Cells to Taxol via NF-κΒ Inhibition and Connexin 43 Upregulation

Scientific Reports
Multidisciplinary
2017English

Angiotensin II Induces RAW264.7 Macrophage Polarization to the M1‑type Through the Connexin 43/NF‑κB Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2020English

Phosphoribosyl Pyrophosphate Synthetases 2 Knockdown Inhibits Prostate Cancer Progression by Suppressing Cell Cycle and Inducing Cell Apoptosis

Journal of Cancer
Oncology
2020English

SIRT1 Inhibits Hepatocellular Carcinoma Metastasis by Promoting M1 Macrophage Polarization via NF-κB Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Upregulation of Connexin 43 and Apoptosis-Associated Protein Expression by High Glucose in H9c2 Cells Was Improved by Resveratrol via the Autophagy Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

CD147 Silencing Inhibits Tumor Growth by Suppressing Glucose Transport in Melanoma

Oncotarget
Oncology
2016English

Down‐regulation of MTHFD2 Inhibits NSCLC Progression by Suppressing Cycle‐related Genes

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

FOXA1 Inhibits Hepatocellular Carcinoma Progression by Suppressing PIK3R1 Expression in Male Patients

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

Osteoinductivity of Calcium Phosphate Mediated by Connexin 43

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy